NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.7600
-0.0020 (-0.26%)
At close: Apr 7, 2026, 4:00 PM EDT
0.7398
-0.0202 (-2.66%)
After-hours: Apr 7, 2026, 7:57 PM EDT
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $26.87 million as of April 7, 2026. Its market cap has increased by 8.09% in one year.
Market Cap
26.87M
Enterprise Value
26.87M
1-Year Change
8.09%
Ranking
Category
Stock Price
$0.76
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $26.87M, a decrease of -58.42%. That is a compound annual growth rate of -18.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 26.87M | 17.63% |
| Dec 31, 2025 | 22.84M | -17.70% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
| Dec 9, 2021 | 64.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BriaCell Therapeutics | 29.39M |
| Senti Biosciences | 28.34M |
| Kyntra Bio | 28.31M |
| Passage Bio | 28.20M |
| Tvardi Therapeutics | 27.63M |
| Exicure | 26.71M |
| Boundless Bio | 26.66M |
| Lexaria Bioscience | 26.38M |